These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 38660833)
1. [Gene Profile and Clinical Significance of Concomitant Mutations in CN-AML Patients with Zhu J; Kang YF; Gao Y; Wang HW; Hao ZH; Wang HW Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):335-341. PubMed ID: 38660833 [TBL] [Abstract][Full Text] [Related]
2. CEBPA double-mutated acute myeloid leukaemia harbours concomitant molecular mutations in 76·8% of cases with TET2 and GATA2 alterations impacting prognosis. Grossmann V; Haferlach C; Nadarajah N; Fasan A; Weissmann S; Roller A; Eder C; Stopp E; Kern W; Haferlach T; Kohlmann A; Schnittger S Br J Haematol; 2013 Jun; 161(5):649-658. PubMed ID: 23521373 [TBL] [Abstract][Full Text] [Related]
3. [Clinical Characteristics and Prognosis of Acute Myeloid Leukemia Patients with Shan RQ; Huang S; Gu ZY; Wang N; Liu DH; Dou LP Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):327-334. PubMed ID: 38660832 [TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of, and gene and microRNA expression signatures associated with, CEBPA mutations in cytogenetically normal acute myeloid leukemia with high-risk molecular features: a Cancer and Leukemia Group B Study. Marcucci G; Maharry K; Radmacher MD; Mrózek K; Vukosavljevic T; Paschka P; Whitman SP; Langer C; Baldus CD; Liu CG; Ruppert AS; Powell BL; Carroll AJ; Caligiuri MA; Kolitz JE; Larson RA; Bloomfield CD J Clin Oncol; 2008 Nov; 26(31):5078-87. PubMed ID: 18809607 [TBL] [Abstract][Full Text] [Related]
5. Clinical significance of FLT3-ITD/CEBPA mutations and minimal residual disease in cytogenetically normal acute myeloid leukemia after hematopoietic stem cell transplantation. Wang H; Li XQ; Chu TT; Han SY; Qi JQ; Tang YQ; Qiu HY; Fu CC; Tang XW; Ruan CG; Wu DP; Han Y J Cancer Res Clin Oncol; 2021 Sep; 147(9):2659-2670. PubMed ID: 33550446 [TBL] [Abstract][Full Text] [Related]
6. Frequency and clinical impact of WT1 mutations in the context of CEBPA-mutated acute myeloid leukemia. Wang T; Hua H; Wang Z; Wang B; Cao L; Qin W; Wu P; Cai X; Chao H; Lu X Hematology; 2022 Dec; 27(1):994-1002. PubMed ID: 36066283 [TBL] [Abstract][Full Text] [Related]
7. [Clinical Significance of Truncated Mutant ΔJBP of TET2 Gene in Patients with Acute Myeloid Leukemia]. Yang YC; Xia T; Luo M; Guo WZ; Zhang LL; Chen XH; Xu ZF; Wang HW; Tan YH Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Aug; 29(4):1011-1018. PubMed ID: 34362476 [TBL] [Abstract][Full Text] [Related]
8. What Is Abnormal in Normal Karyotype Acute Myeloid Leukemia in Children? Analysis of the Mutational Landscape and Prognosis of the TARGET-AML Cohort. Herlin MK; Yones SA; Kjeldsen E; Holmfeldt L; Hasle H Genes (Basel); 2021 May; 12(6):. PubMed ID: 34064268 [TBL] [Abstract][Full Text] [Related]
9. CEBPA gene mutations in Egyptian acute myeloid leukemia patients: impact on prognosis. Awad MM; Aladle DA; Abousamra NK; Elghannam DM; Fawzy IM Hematology; 2013 Mar; 18(2):61-8. PubMed ID: 22990006 [TBL] [Abstract][Full Text] [Related]
11. TET2 mutations improve the new European LeukemiaNet risk classification of acute myeloid leukemia: a Cancer and Leukemia Group B study. Metzeler KH; Maharry K; Radmacher MD; Mrózek K; Margeson D; Becker H; Curfman J; Holland KB; Schwind S; Whitman SP; Wu YZ; Blum W; Powell BL; Carter TH; Wetzler M; Moore JO; Kolitz JE; Baer MR; Carroll AJ; Larson RA; Caligiuri MA; Marcucci G; Bloomfield CD J Clin Oncol; 2011 Apr; 29(10):1373-81. PubMed ID: 21343549 [TBL] [Abstract][Full Text] [Related]
12. Incidences and Prognostic Impact of c-KIT, WT1, CEBPA, and CBL Mutations, and Mutations Associated With Epigenetic Modification in Core Binding Factor Acute Myeloid Leukemia: A Multicenter Study in a Korean Population. Park SH; Lee HJ; Kim IS; Kang JE; Lee EY; Kim HJ; Kim YK; Won JH; Bang SM; Kim H; Song MK; Chung JS; Shin HJ Ann Lab Med; 2015 May; 35(3):288-97. PubMed ID: 25932436 [TBL] [Abstract][Full Text] [Related]
13. Companion gene mutations and their clinical significance in AML with double or single mutant CEBPA. He J; Liu J; Shen H; Wang Z; Cao L; Wu P; Chao H; Lu X; Jia Z; Chen M; Cai X Int J Hematol; 2022 Jul; 116(1):71-80. PubMed ID: 35314954 [TBL] [Abstract][Full Text] [Related]
14. [Clinical Characteristics and Prognostic Relevance of Co-Mutated Genes in Acute Myeloid Leukemia Patients with Chen Y; Xie YY; Fang Y; Hong M; Liu WJ; Zhou X; Zhang W; Shi JN; Qian SX Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Aug; 32(4):1032-1038. PubMed ID: 39192394 [TBL] [Abstract][Full Text] [Related]
15. Mutation profile and associated clinical features in Chinese patients with cytogenetically normal acute myeloid leukemia. Wang S; Zhang YX; Huang T; Sui JN; Lu J; Chen XJ; Wang KK; Xi XD; Li JM; Huang JY; Chen B Int J Lab Hematol; 2018 Aug; 40(4):408-418. PubMed ID: 29573577 [TBL] [Abstract][Full Text] [Related]
16. Favorable prognostic impact of NPM1 mutations in older patients with cytogenetically normal de novo acute myeloid leukemia and associated gene- and microRNA-expression signatures: a Cancer and Leukemia Group B study. Becker H; Marcucci G; Maharry K; Radmacher MD; Mrózek K; Margeson D; Whitman SP; Wu YZ; Schwind S; Paschka P; Powell BL; Carter TH; Kolitz JE; Wetzler M; Carroll AJ; Baer MR; Caligiuri MA; Larson RA; Bloomfield CD J Clin Oncol; 2010 Feb; 28(4):596-604. PubMed ID: 20026798 [TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of CEBPA mutations and BAALC expression in acute myeloid leukemia Egyptian patients with normal karyotype. El-Sharnouby JA; Ahmed LM; Taha AM; Kamal O Egypt J Immunol; 2008; 15(1):131-43. PubMed ID: 20306678 [TBL] [Abstract][Full Text] [Related]
19. Risk assessment in patients with acute myeloid leukemia and a normal karyotype. Bienz M; Ludwig M; Leibundgut EO; Mueller BU; Ratschiller D; Solenthaler M; Fey MF; Pabst T Clin Cancer Res; 2005 Feb; 11(4):1416-24. PubMed ID: 15746041 [TBL] [Abstract][Full Text] [Related]
20. [NPM1 and CEBPA mutations in pediatric cytogenetically normal acute myeloid leukemia]. Ruan M; Zhang L; Han C; Liu X; Ai X; Zhang J; Liu T; Yang W; Chen X; Guo Y; Wang S; Li Q; Zou Y; Chen Y; Zhu X Zhonghua Er Ke Za Zhi; 2014 Apr; 52(4):303-7. PubMed ID: 24915920 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]